Skip to Content
Morningstar

Cencora Inc COR

Morningstar Rating
Unlock
Stock XNYS Rating as of
$237.69 +0.84 (0.35%)
View Full Chart
As of Delayed Price Post-Trading: $237.69 0.00
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Cencora Continues to See Robust Growth From GLP-1s at the Cost of Margin Depression

Keonhee Kim

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $200 billion in annual U.S. healthcare distribution sales, the company supplies roughly one third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market.

Read Full Report

Price vs Fair Value

View History
COR is trading at a 29% premium.
Price
$236.85
Fair Value
$965.00
Uncertainty
Medium
1-Star Price
$841.14
5-Star Price
$278.10
Economic Moat
Twyjp
Capital Allocation
Mpvxdyxzk

Bulls Say, Bears Say

Bulls

Cencora distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cencora's profitability.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COR is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$236.85
Day Range
$236.25–238.72
52-Week Range
$163.37–246.75
Bid/Ask
$232.19 / $255.00
Market Cap
$47.36 Bil
Volume/Avg
1.4 Mil / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
18.89
Price/Sales
0.18
Dividend Yield (Trailing)
0.84%
Dividend Yield (Forward)
0.86%
Total Yield
2.44%

Company Profile

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
46,000
Website
https://www.cencora.com

Competitors

Valuation

View More
Metric
COR
CAH
MCK
Price/Earnings (Normalized)
 18.8915.0318.25
Price/Book Value
 51.92——
Price/Sales
 0.180.120.23
Price/Cash Flow
 14.8210.7114.94
Price/Earnings
COR
CAH
MCK

Financial Strength

Metric
COR
CAH
MCK
Quick Ratio
 0.480.430.48
Current Ratio
 0.880.980.92
Interest Coverage
 9.4118.3714.72
Quick Ratio
COR
CAH
MCK

Profitability

Metric
COR
CAH
MCK
Return on Assets (Normalized)
 4.19%3.89%6.00%
Return on Equity (Normalized)
 574.41%——
Return on Invested Capital (Normalized)
 48.08%89.85%66.76%
Return on Assets
COR
CAH
MCK
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Distribution Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpCfyhlvxfPhhttc$69.0 Bil
CAH
Cardinal Health IncMhzkrtbRtgchh$26.3 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H—Sqlpd$8.2 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class H—Fqkfzl$8.0 Bil
SHTDF
Sinopharm Group Co Ltd—Vtphcg$7.9 Bil
SHTDY
Sinopharm Group Co Ltd ADR—Jqrsxs$7.9 Bil
AMFPF
Amplifon SpA Az nom Post Frazionamento—Sysrjg$7.6 Bil
MAHLY
Medipal Holdings Corp ADR—Fjry$3.3 Bil
MEPDF
Medipal Holdings Corp—Wjcq$3.2 Bil

Sponsor Center